"We want to help keep your joints, muscles and bones healthy, and are always available to talk with you and address your concerns. Contact us today for a rheumatologist in Smithtown!"

During the past decade, Rheumatology Associates of Long Island conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 9 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rheumatology Associates of Long Island" #1 sponsor was "Genentech, Inc." with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Human Genome Sciences Inc." with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Crescendo Bioscience" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rheumatology Associates of Long Island" #1 collaborator was "GlaxoSmithKline" with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Laboratory Corporation of America" with 1 trials as a collaborator, "National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)" with 1 trials as a collaborator and "NorthShore University HealthSystem" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Rheumatology Associates of Long Island" are "Rheumatoid Arthritis" (8 trials), "Arthritis, Rheumatoid" (2 trials), "Systemic Lupus Erythematosus" (2 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Depression" (1 trials). Many other conditions were trialed in "Rheumatology Associates of Long Island" in a lesser frequency.

Most popular intervention types in "Rheumatology Associates of Long Island" are "Drug" (10 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Abatacept" (1 trials), "Adalimumab" (1 trials), "Belimumab 1 mg/kg" (1 trials) and "Belimumab 10 mg/kg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rheumatology Associates of Long Island" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Rheumatology Associates of Long Island". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Rheumatology Associates of Long Island, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Rheumatology Associates of Long Island, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".